Skip to main content
OpenTrials
Completed

NCT Number: NCT06364137

Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

The research study will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the pilot trial will examine examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Completed

Looking for future studies?

Notify Me

Key information

Age range

5 year–14 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Stanford University

Stanford, California, 94305, United States

About this study

The research study will examine engagement in telehealth for children undergoing psychotherapy. The study in Phase I entails a pilot randomized trial with a goal to enroll 42 families, examining patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Engagement will be assessed using well-established measures - PRIME-O (modified) video coding (session 1), MTT-Y/MTTCG (sessions 1, 4) and attendance data (sessions 1-4). Clinicians in the study will deliver therapy to clients for 4 sessions, providing opportunity to measure temporal sustainment of any engagement differences.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Receiving psychotherapy with a licensed professional on the Teleo platform
  • Likely have at least 12 sessions remaining.
  • Diagnosis of a mental health condition by a licensed clinician

Exclusion criteria

  • Not under treatment with provider using Teleo platform

Treatment and study plan

Teleo

Other

Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.

Standard Videoconferencing

Other

Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform

Primary outcomes

  1. PRIME-O Video Coding Score

    Time frame: Weeks 1, 2, 3, 4

    Assess therapeutic engagement using modified PRIME-O total score, group scores, and individual item sub-scores. Scores range from 0-40, higher scores indicate 'better' outcome.

Secondary outcomes

  1. My Thoughts about Therapy - Caregiver (MTT-CG) engagement questionnaire scores

    Time frame: Post-intervention (at one month)

    Caregivers will complete modified MTT-CG questionnaire to measure engagement across dimensions of the REACH client engagement framework - Relationship, Expectancy, Attendance, Clarity, and Homework. Scores range from 0-105, higher scores indicate 'better' outcome.

  2. My Thoughts about Therapy - Youth (MTT-Y) engagement questionnaire scores

    Time frame: Post-intervention (at one month)

    Youth will complete questionnaires to measure self-reported engagement across dimensions of the REACH client engagement framework - Relationship, Expectancy, Attendance, Clarity, and Homework. Scores range from 0-105, higher scores indicate 'better' outcome.

  3. Attendance during Psychotherapy Sessions

    Time frame: One month

    Instances and frequency of appointment cancellations, appointment no-shows, and/or discontinuation of therapy will be recorded and analyzed.

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Collaborators

  • MainSquare Co. (dba 'Teleo')
  • National Institute of Mental Health (NIMH)

Registry information

Official study title

Engagement and Clinical Impact of the Teleo Virtual Therapy Platform

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Apr 15, 2024
Registry last updated
Sep 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.